Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6804113

CC(C)(C)c1ccc(S(=O)(=O)C2CCN(CCCC(=O)c3ccc4c(c3)CCNCC4)CC2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 15/20 0.56
DRD2 P14416 2/20 0.51
HTR2A P28223 2/20 0.51
ACHE P22303 2/20 0.46
CYP2J2 P51589 1/20 0.46
MLNR O43193 2/20 0.44
NPC1 O15118 1/20 0.44
NR1I2 O75469 1/20 0.44
EGFR P00533 1/20 0.44
LMNA P02545 1/20 0.44
ERBB2 P04626 1/20 0.44
FYN P06241 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
ABCB1 P08183 1/20 0.44
ADRB1 P08588 1/20 0.44
HTR1A P08908 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6802636 0.80 MCHR1 (0.58) MCHR1DRD2HTR2AACHEHTR1A
Trifluoroacetic Acid SCHEMBL6799996 0.79 MCHR1 (0.56) MCHR1ACHE
Trifluoroacetic Acid SCHEMBL6807608 0.79 MCHR1 (0.62) MCHR1DRD2HTR2AACHEHTR1A
Trifluoroacetic Acid SCHEMBL6807539 0.79 MCHR1 (0.54) MCHR1ACHELMNA
Trifluoroacetic Acid SCHEMBL6796675 0.79 MCHR1 (0.89) MCHR1DRD2ACHE
Trifluoroacetic Acid SCHEMBL6795286 0.79 MCHR1 (0.60) MCHR1ACHESLC6A2SLC6A4
Trifluoroacetic Acid SCHEMBL6806017 0.78 MCHR1 (0.61) MCHR1DRD2HTR2AACHELMNA
Trifluoroacetic Acid SCHEMBL6800430 0.78 MCHR1 (0.64) MCHR1DRD2HTR2AACHEHTR1A
Trifluoroacetic Acid SCHEMBL6799476 0.78 MCHR1 (0.60) MCHR1DRD2HTR2AACHEHTR1A
Trifluoroacetic Acid SCHEMBL6799963 0.77 MCHR1 (0.68) MCHR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063699-A1 Gpr14 antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-01 US disclosed
EP-1310490-A1 GPR14 ANTAGONIST Takeda Chemical Industries, Ltd. (JP) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063699-A1 Gpr14 antagonist GPR142, GPR139, GPR4 MCHR1 191/4885DRD2 329/4885HTR2A 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.